Zydus can sell anti-cancer drug Nivolumab biosimilar in India, says Delhi high court
New Delhi: In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anti-cancer…





